Overview: Imaging Endpoints (IE) has established a strong reputation for quality through a perfect inspection record and remarkable marketing authorization success rate and is expanding its quality leadership by integrating the new standards of ICH E6 (R3) into IE’s Quality… Read More
May 7, 2024 SCOTTSDALE, AZ – Imaging Endpoints (IE), a global leader in Imaging CRO technologies and services, has announced the formation of a new subsidiary, Revolution EndpointsTM, focused on leveraging the Company’s strong leadership and financial position to acquire… Read More
On Tuesday, 23 April 2024, the U.S. FDA granted accelerated approval to Day One Biopharmaceuticals for tovorafenib, the first targeted therapy for relapsed or refractory BRAF-altered pediatric low-grade glioma (pLGG). As explained in Day One’s press release, “pLGG is the… Read More
January 2024 – Imaging Endpoints (IE) is a global leader specializing in comprehensive imaging services for clinical trials. Our profound expertise includes analysis of CT, MRI, and PET/SPECT molecular imaging, particularly in the context of gynecologic malignancies, including cervical cancer.… Read More
September is a significant month for many reasons, but in the medical community, it stands out as Childhood Cancer Awareness Month. This month, we spotlight the pressing global health challenge of childhood cancer, which remains one of the leading causes… Read More
SCOTTSDALE, AZ — Imaging Endpoints (IE), the global leader in oncology-trial imaging and among the largest imaging CROs (iCROs) globally, is pleased to announce the appointment of Manish Sharma, MD as its Chief Scientific Officer. Dr Sharma, a radiologist with… Read More
Company’s Vast Oncology Experience Leads Industry in Marketing Authorizations Scottsdale, Arizona, April 25, 2023, Imaging Endpoints (IE) announced today that it has achieved a remarkable 95% regulatory approval rate in over one-hundred marketing authorizations and associated inspections by regulatory agencies… Read More
March 24, 2023 Abstract Despite a growing number of effective therapeutic options for patients with pancreatic adenocarcinoma, the prognosis remains dismal mostly due to the late-stage presentation and spread of the cancer to other organs. Because a genomic analysis of… Read More
February 2nd, 2023 SCOTTSDALE, AZ — Imaging Endpoints (IE), the world’s largest oncology-focused imaging CRO, announced today the addition of Steven P. Rowe, M.D., Ph.D., to the company’s Scientific Advisory Board (SAB). Dr. Rowe is an Associate Professor of Radiology… Read More
November 16, 2022 SCOTTSDALE, AZ — Imaging Endpoints (IE), the world’s largest oncology-focused imaging CRO, announced today the addition of Joy (Huan) Zhu, M.D., Ph.D., to the company as Vice President, Medical Operations. Prior to joining IE, Joy spent 25… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
